We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.67B
AUM Growth
+$134M
Cap. Flow
+$180M
Cap. Flow %
10.83%
Top 10 Hldgs %
42.41%
Holding
98
New
25
Increased
27
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$39.2M
2
UTHR icon
United Therapeutics
UTHR
+$36.1M
3
CAR icon
Avis
CAR
+$33.4M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$33.3M
5
RL icon
Ralph Lauren
RL
+$29M

Top Sells

Rank Stock Value
1
SGI
Somnigroup International
SGI
+$40.4M
2
PRKS icon
United Parks & Resorts
PRKS
+$34.4M
3
INCY icon
Incyte
INCY
+$29.4M
4
CVS icon
CVS Health
CVS
+$28.6M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 37.02%
2 Consumer Discretionary 19.39%
3 Consumer Staples 7.59%
4 Industrials 2.26%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DESP
26
DELISTED
Despegar.com
DESP
$26.4M 1.58%
1,564,000
-28,000
-2% -$524K
LNW
27
DELISTED
Light & Wonder
LNW
$22.9M 1.37%
900,000
+532,000
+145% +$19.3M
VNDA icon
28
Vanda Pharmaceuticals
VNDA
$304M
$20.7M 1.24%
900,000
-1,324,000
-60% -$27M
QVCGA
29
DELISTED
QVC Group Inc Series A
QVCGA
$20M 1.2%
18,540
+8,446
+84% +$8.88M
ASRT
30
DELISTED
Assertio
ASRT
$17.6M 1.06%
50,000
+30,368
+155% +$13.3M
PETS icon
31
PetMed Express
PETS
$42.3M
$17.6M 1.05%
+532,000
New +$19.9M
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$12.6B
$17.1M 1.03%
+80,000
New +$20.1M
CLLS
33
Cellectis
CLLS
$288M
$16.9M 1.02%
+600,000
New +$17.2M
BBY icon
34
Best Buy
BBY
$19B
$15.9M 0.95%
200,000
+60,000
+43% +$4.65M
GAP
35
The Gap Inc
GAP
$7.3B
$15.1M 0.91%
524,000
-336,000
-39% -$10.1M
LRMR icon
36
Larimar Therapeutics
LRMR
$377M
$13.6M 0.82%
97,000
-28,000
-22% -$3.4M
SBBP
37
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.9M 0.77%
2,650,000
+492,000
+23% +$2.52M
BLUE
38
DELISTED
bluebird bio
BLUE
$12.8M 0.77%
6,794
-7,102
-51% -$14.7M
ONCE
39
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$12.4M 0.75%
228,000
+78,000
+52% +$5.33M
RDUS
40
DELISTED
Radius Health, Inc.
RDUS
$11.7M 0.7%
+658,000
New +$14.9M
PRTK
41
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11.6M 0.7%
1,200,000
+68,000
+6% +$686K
ATEC icon
42
Alphatec Holdings
ATEC
$1.48B
$11.1M 0.67%
3,300,414
+70,000
+2% +$221K
EAT icon
43
Brinker International
EAT
$8.82B
$9.35M 0.56%
+200,000
New +$9.32M
BDSI
44
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$9.22M 0.55%
3,292,000
+3,171,111
+2,623% +$8.9M
FND icon
45
Floor & Decor
FND
$6.03B
$9.05M 0.54%
+300,000
New +$12.2M
META icon
46
Meta Platforms (Facebook)
META
$1.49T
$8.22M 0.49%
50,000
+32,000
+178% +$5.79M
LULU icon
47
lululemon athletica
LULU
$13.5B
$8.13M 0.49%
+50,000
New +$6.85M
CVS icon
48
CVS Health
CVS
$135B
$7.87M 0.47%
100,000
-400,000
-80% -$28.6M
SLDB icon
49
Solid Biosciences
SLDB
$792M
$7.74M 0.46%
10,933
-1,067
-9% -$670K
TLRD
50
DELISTED
Tailored Brands, Inc.
TLRD
$7.56M 0.45%
+300,000
New +$6.89M
1
2
3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Armistice Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Armistice Capital held 98 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Armistice Capital deployed $180M of net new capital in Q3 2018, opening 25 new positions and adding to 27 existing holdings. Its largest new stake was United Therapeutics: 292,000 shares worth $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Somnigroup International, an estimated $40.4M trimmed.

  • Armistice Capital's largest Q3 2018 buy was United Therapeutics: 292,000 shares worth $37.3M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q3 2018, an estimated $39.2M increase.
  • Armistice Capital's biggest Q3 2018 reduction was Somnigroup International, cutting an estimated $40.4M.
  • Armistice Capital fully exited United Parks & Resorts in Q3 2018, selling an estimated $34.4M.
  • Armistice Capital's ten largest holdings make up 42% of its $1.67B portfolio in Q3 2018.
  • Armistice Capital opened 25 new positions and closed 21 in Q3 2018.
  • Armistice Capital's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on Armistice Capital's 13F filing for Q3 2018, filed 14 Nov 2018.